New drug from Waltham company gets FDA authorization to protect immunocompromised patients from COVID : vimarsana.com

Invivyd Inc. announced on March 22 that its monoclonal antibody, Pemgarda, had received emergency use authorization from the US Food and Drug Administration.

Related Keywords

United States , American , Cameronr Wolfe , , Duke University School Of Medicine , American Medical Association , Duke University School ,